Community pharmacy personnel interventions for smoking cessation (Review)

Kristin V. Carson-Chahhoud* (Corresponding Author), Jonathan Livingstone-Banks, Kelsey J. Sharrad, Zoe Kopsaftis, Malcolm P. Brinn, Rachada To-A-Nan, Christine M. Bond

*Corresponding author for this work

Research output: Contribution to journalArticle

Abstract

Background
Community pharmacists could provide effective smoking cessation treatment because they offer easy access to members of the community. They are well placed to provide both advice on the correct use of smoking cessation products and behavioural support to aid smoking cessation.

Objectives
To assess the effectiveness of interventions delivered by community pharmacy personnel to assist people to stop smoking, with or without
concurrent use of pharmacotherapy.

Search methods
We searched the Cochrane Tobacco Addiction Group Specialised Register, along with clinicaltrials.gov and the ICTRP, for smoking cessation studies conducted in a community pharmacy setting, using the search terms pharmacist* or pharmacy or pharmacies. Date of the most recent search: January 2019.

Selection criteria
Randomised controlled trials of interventions delivered by community pharmacy personnel to promote smoking cessation amongst their clients who were smokers, compared with usual pharmacy support or any less intensive programme. The main outcome measure was smoking cessation rates at six months or more after the start of the intervention.

Data collection and analysis
We used standard methodological procedures expected by Cochrane for study screening, data extraction and management.We conducted a meta-analysis using a Mantel-Haenszel random-effects model to generate risk ratios (RRs) and 95% confidence intervals (CIs).

Main results
We identified seven studies including 1774 participants. We judged three studies to be at high risk of bias and four to be at unclear risk. Each study provided face-to-face behavioural support delivered by pharmacy staff, and required pharmacy personnel training. Typically such programmes comprised support starting before quit day and continuing with weekly appointments for several weeks afterwards. Comparators were either minimal or less intensive behavioural support for smoking cessation, typically comprising a few minutes of one-off advice on how to quit. Participants in both intervention and control arms received equivalent smoking cessation pharmacotherapy in all but one study. All studies took place in high-income countries, and recruited participants visiting pharmacies.We pooled six studies of 1614 participants and detected a benefit of more intensive behavioural smoking cessation interventions delivered by community pharmacy personnel compared with less intensive cessation interventions at longest follow-up (RR 2.30, 95% CI 1.33 to 3.97; I2 = 54%; low-certainty evidence).

Authors' conclusions
Community pharmacists can provide effective behavioural support to people trying to stop smoking. However, this conclusion is based on low-certainty evidence, limited by risk of bias and imprecision. Further research could change this conclusion.
Original languageEnglish
Article numberCD003698
Number of pages40
JournalCochrane Database of Systematic Reviews
Volume2019
Issue number10
DOIs
Publication statusPublished - 31 Oct 2019

Fingerprint

Pharmacies
Smoking Cessation
Pharmacists
Smoking
Odds Ratio
Confidence Intervals
Tobacco Use Cessation Products
Drug Therapy
Withholding Treatment
Tobacco
Meta-Analysis
Appointments and Schedules
Outcome Assessment (Health Care)
Research

Cite this

Carson-Chahhoud, K. V., Livingstone-Banks, J., Sharrad, K. J., Kopsaftis, Z., Brinn, M. P., To-A-Nan, R., & Bond, C. M. (2019). Community pharmacy personnel interventions for smoking cessation (Review). Cochrane Database of Systematic Reviews, 2019(10), [CD003698]. https://doi.org/10.1002/14651858.CD003698.pub3

Community pharmacy personnel interventions for smoking cessation (Review). / Carson-Chahhoud, Kristin V. (Corresponding Author); Livingstone-Banks, Jonathan; Sharrad, Kelsey J.; Kopsaftis, Zoe; Brinn, Malcolm P.; To-A-Nan, Rachada; Bond, Christine M.

In: Cochrane Database of Systematic Reviews, Vol. 2019, No. 10, CD003698, 31.10.2019.

Research output: Contribution to journalArticle

Carson-Chahhoud, KV, Livingstone-Banks, J, Sharrad, KJ, Kopsaftis, Z, Brinn, MP, To-A-Nan, R & Bond, CM 2019, 'Community pharmacy personnel interventions for smoking cessation (Review)', Cochrane Database of Systematic Reviews, vol. 2019, no. 10, CD003698. https://doi.org/10.1002/14651858.CD003698.pub3
Carson-Chahhoud KV, Livingstone-Banks J, Sharrad KJ, Kopsaftis Z, Brinn MP, To-A-Nan R et al. Community pharmacy personnel interventions for smoking cessation (Review). Cochrane Database of Systematic Reviews. 2019 Oct 31;2019(10). CD003698. https://doi.org/10.1002/14651858.CD003698.pub3
Carson-Chahhoud, Kristin V. ; Livingstone-Banks, Jonathan ; Sharrad, Kelsey J. ; Kopsaftis, Zoe ; Brinn, Malcolm P. ; To-A-Nan, Rachada ; Bond, Christine M. / Community pharmacy personnel interventions for smoking cessation (Review). In: Cochrane Database of Systematic Reviews. 2019 ; Vol. 2019, No. 10.
@article{90739b5ee95c427d81930bc9790b9d45,
title = "Community pharmacy personnel interventions for smoking cessation (Review)",
abstract = "BackgroundCommunity pharmacists could provide effective smoking cessation treatment because they offer easy access to members of the community. They are well placed to provide both advice on the correct use of smoking cessation products and behavioural support to aid smoking cessation.ObjectivesTo assess the effectiveness of interventions delivered by community pharmacy personnel to assist people to stop smoking, with or withoutconcurrent use of pharmacotherapy.Search methodsWe searched the Cochrane Tobacco Addiction Group Specialised Register, along with clinicaltrials.gov and the ICTRP, for smoking cessation studies conducted in a community pharmacy setting, using the search terms pharmacist* or pharmacy or pharmacies. Date of the most recent search: January 2019.Selection criteriaRandomised controlled trials of interventions delivered by community pharmacy personnel to promote smoking cessation amongst their clients who were smokers, compared with usual pharmacy support or any less intensive programme. The main outcome measure was smoking cessation rates at six months or more after the start of the intervention.Data collection and analysisWe used standard methodological procedures expected by Cochrane for study screening, data extraction and management.We conducted a meta-analysis using a Mantel-Haenszel random-effects model to generate risk ratios (RRs) and 95{\%} confidence intervals (CIs).Main resultsWe identified seven studies including 1774 participants. We judged three studies to be at high risk of bias and four to be at unclear risk. Each study provided face-to-face behavioural support delivered by pharmacy staff, and required pharmacy personnel training. Typically such programmes comprised support starting before quit day and continuing with weekly appointments for several weeks afterwards. Comparators were either minimal or less intensive behavioural support for smoking cessation, typically comprising a few minutes of one-off advice on how to quit. Participants in both intervention and control arms received equivalent smoking cessation pharmacotherapy in all but one study. All studies took place in high-income countries, and recruited participants visiting pharmacies.We pooled six studies of 1614 participants and detected a benefit of more intensive behavioural smoking cessation interventions delivered by community pharmacy personnel compared with less intensive cessation interventions at longest follow-up (RR 2.30, 95{\%} CI 1.33 to 3.97; I2 = 54{\%}; low-certainty evidence).Authors' conclusionsCommunity pharmacists can provide effective behavioural support to people trying to stop smoking. However, this conclusion is based on low-certainty evidence, limited by risk of bias and imprecision. Further research could change this conclusion.",
author = "Carson-Chahhoud, {Kristin V.} and Jonathan Livingstone-Banks and Sharrad, {Kelsey J.} and Zoe Kopsaftis and Brinn, {Malcolm P.} and Rachada To-A-Nan and Bond, {Christine M.}",
note = "A C K N O W L E D G E M E N T S Amanda Lee provided statistical advice. Our thanks to previous authors: Hazel Sinclair and Lindsay Stead. We would also like to thank Rachna Begh and Ali Albasri for peer review, and Sandra Wilcox for performing consumer review. This project was supported by the National Institute for Health Research (NIHR), via Cochrane Infrastructure and Cochrane Programme Grant funding to the Cochrane Tobacco Addiction Group. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or the Department of Health and Social Care. S O U R C E S O F S U P P O R T Internal sources • University of Aberdeen, UK. • Nuffield Department of Primary Care Health Sciences, University of Oxford, UK. External sources • NIHR Cochrane Infrastructure Grant, UK. • NIHR Cochrane Programme Grant, UK.",
year = "2019",
month = "10",
day = "31",
doi = "10.1002/14651858.CD003698.pub3",
language = "English",
volume = "2019",
journal = "Cochrane Database of Systematic Reviews",
issn = "1469-493X",
publisher = "Wiley",
number = "10",

}

TY - JOUR

T1 - Community pharmacy personnel interventions for smoking cessation (Review)

AU - Carson-Chahhoud, Kristin V.

AU - Livingstone-Banks, Jonathan

AU - Sharrad, Kelsey J.

AU - Kopsaftis, Zoe

AU - Brinn, Malcolm P.

AU - To-A-Nan, Rachada

AU - Bond, Christine M.

N1 - A C K N O W L E D G E M E N T S Amanda Lee provided statistical advice. Our thanks to previous authors: Hazel Sinclair and Lindsay Stead. We would also like to thank Rachna Begh and Ali Albasri for peer review, and Sandra Wilcox for performing consumer review. This project was supported by the National Institute for Health Research (NIHR), via Cochrane Infrastructure and Cochrane Programme Grant funding to the Cochrane Tobacco Addiction Group. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or the Department of Health and Social Care. S O U R C E S O F S U P P O R T Internal sources • University of Aberdeen, UK. • Nuffield Department of Primary Care Health Sciences, University of Oxford, UK. External sources • NIHR Cochrane Infrastructure Grant, UK. • NIHR Cochrane Programme Grant, UK.

PY - 2019/10/31

Y1 - 2019/10/31

N2 - BackgroundCommunity pharmacists could provide effective smoking cessation treatment because they offer easy access to members of the community. They are well placed to provide both advice on the correct use of smoking cessation products and behavioural support to aid smoking cessation.ObjectivesTo assess the effectiveness of interventions delivered by community pharmacy personnel to assist people to stop smoking, with or withoutconcurrent use of pharmacotherapy.Search methodsWe searched the Cochrane Tobacco Addiction Group Specialised Register, along with clinicaltrials.gov and the ICTRP, for smoking cessation studies conducted in a community pharmacy setting, using the search terms pharmacist* or pharmacy or pharmacies. Date of the most recent search: January 2019.Selection criteriaRandomised controlled trials of interventions delivered by community pharmacy personnel to promote smoking cessation amongst their clients who were smokers, compared with usual pharmacy support or any less intensive programme. The main outcome measure was smoking cessation rates at six months or more after the start of the intervention.Data collection and analysisWe used standard methodological procedures expected by Cochrane for study screening, data extraction and management.We conducted a meta-analysis using a Mantel-Haenszel random-effects model to generate risk ratios (RRs) and 95% confidence intervals (CIs).Main resultsWe identified seven studies including 1774 participants. We judged three studies to be at high risk of bias and four to be at unclear risk. Each study provided face-to-face behavioural support delivered by pharmacy staff, and required pharmacy personnel training. Typically such programmes comprised support starting before quit day and continuing with weekly appointments for several weeks afterwards. Comparators were either minimal or less intensive behavioural support for smoking cessation, typically comprising a few minutes of one-off advice on how to quit. Participants in both intervention and control arms received equivalent smoking cessation pharmacotherapy in all but one study. All studies took place in high-income countries, and recruited participants visiting pharmacies.We pooled six studies of 1614 participants and detected a benefit of more intensive behavioural smoking cessation interventions delivered by community pharmacy personnel compared with less intensive cessation interventions at longest follow-up (RR 2.30, 95% CI 1.33 to 3.97; I2 = 54%; low-certainty evidence).Authors' conclusionsCommunity pharmacists can provide effective behavioural support to people trying to stop smoking. However, this conclusion is based on low-certainty evidence, limited by risk of bias and imprecision. Further research could change this conclusion.

AB - BackgroundCommunity pharmacists could provide effective smoking cessation treatment because they offer easy access to members of the community. They are well placed to provide both advice on the correct use of smoking cessation products and behavioural support to aid smoking cessation.ObjectivesTo assess the effectiveness of interventions delivered by community pharmacy personnel to assist people to stop smoking, with or withoutconcurrent use of pharmacotherapy.Search methodsWe searched the Cochrane Tobacco Addiction Group Specialised Register, along with clinicaltrials.gov and the ICTRP, for smoking cessation studies conducted in a community pharmacy setting, using the search terms pharmacist* or pharmacy or pharmacies. Date of the most recent search: January 2019.Selection criteriaRandomised controlled trials of interventions delivered by community pharmacy personnel to promote smoking cessation amongst their clients who were smokers, compared with usual pharmacy support or any less intensive programme. The main outcome measure was smoking cessation rates at six months or more after the start of the intervention.Data collection and analysisWe used standard methodological procedures expected by Cochrane for study screening, data extraction and management.We conducted a meta-analysis using a Mantel-Haenszel random-effects model to generate risk ratios (RRs) and 95% confidence intervals (CIs).Main resultsWe identified seven studies including 1774 participants. We judged three studies to be at high risk of bias and four to be at unclear risk. Each study provided face-to-face behavioural support delivered by pharmacy staff, and required pharmacy personnel training. Typically such programmes comprised support starting before quit day and continuing with weekly appointments for several weeks afterwards. Comparators were either minimal or less intensive behavioural support for smoking cessation, typically comprising a few minutes of one-off advice on how to quit. Participants in both intervention and control arms received equivalent smoking cessation pharmacotherapy in all but one study. All studies took place in high-income countries, and recruited participants visiting pharmacies.We pooled six studies of 1614 participants and detected a benefit of more intensive behavioural smoking cessation interventions delivered by community pharmacy personnel compared with less intensive cessation interventions at longest follow-up (RR 2.30, 95% CI 1.33 to 3.97; I2 = 54%; low-certainty evidence).Authors' conclusionsCommunity pharmacists can provide effective behavioural support to people trying to stop smoking. However, this conclusion is based on low-certainty evidence, limited by risk of bias and imprecision. Further research could change this conclusion.

U2 - 10.1002/14651858.CD003698.pub3

DO - 10.1002/14651858.CD003698.pub3

M3 - Article

VL - 2019

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

SN - 1469-493X

IS - 10

M1 - CD003698

ER -